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ance rate was 67% for women receiving a single drug and 22%
for multiple drug treatment. The rate of switching was 89% in
non-compliant and 68% in the compliant groups. CONCLU-
SIONS: The rate of compliance was lower for women on 
multiple drugs compared to those on single drug therapy. Non-
compliant women are more likely to switch drug therapies than
the compliant women.
POS14
HOME AUTOMATED TELEMANAGEMENT IN POST-HIP
FRACTURE REHABILITATION
Finkelstein J, Joshi A, Rozmarin E, Baumgarten M
University of Maryland, Baltimore, MD, USA
OBJECTIVES: The objective of the study is to assess the feasi-
bility and acceptance of computer-mediated home-based reha-
bilitation of hip fracture patients. METHODS: A structured
exercise program was developed by a physical therapist (PT) and
incorporated into a website where the PT could prescribe,
monitor, and modify an individualized exercise plan. The
patients were given a laptop computer that was operated by a
limited number of keys. The computer guided the patients
through their exercise programs and sent daily exercise logs to
a central server which analyzed patient performance and alerted
the PT if certain clinical condition were met. Overall, ten patients
were enrolled in the study who were monitored for 30 days.
RESULTS: The average age of the subjects was 76 ± 9 years in
whom number of days since hip fracture was 159 ± 143. There
was a signiﬁcant improvement from the beginning to the end of
the study in exercise self-efﬁcacy (6 ± 3 vs. 9 ± 1; p = 0.01),
Lower Extremity Functional Scale (55 ± 16 vs. 63 ± 13; p = 0.03),
and quality of life scale (SF-36) including physical functioning
(38 ± 27 vs. 71 ± 31; p = 0.009), physical problems limitations
(6 ± 10 vs. 17 ± 12; p = 0.05), social functioning (54 ± 31 vs.
85 ± 28; p = 0.01) and health transition (47 ± 40 vs. 22 ± 18; p
= 0.05). Using Yale Physical Activity Survey we found improve-
ment in physical intensity measured as total hours/week (24 ±
14 vs. 31 ± 14; p = 0.04). Based on the Client Satisfaction Ques-
tionnaire (CSQ-8), patient satisfaction with their medical care
also improved (27 ± 4 vs. 31 ± 0.46; p = 0.04). Adherence to the
exercises was above 89%. CONCLUSION: Computer-mediated
home-based rehabilitation program could be beneﬁcial for post-
acute hip fracture recovery.
OTHER—Cost Studies
POT1
INCIDENCE AND ECONOMIC IMPACT ANALYSIS OF
HYPONATREMIA IN HOSPITALIZED PATIENTS
Long J, Proach J
Triage HealthCom, LLC, Lawrenceville, NJ, USA
OBJECTIVES: To examine the incidence and potential ﬁnancial
impact of diseases with associated hyponatremia among hospi-
talized patients in the United States. METHODS: A retrospec-
tive analysis of Medicare inpatient coding procedures, length of
stay (LOS) and Medicare hospital reimbursement data (2004) to
estimate direct costs of 176 private, for-proﬁt hospitals with
coding accuracy validated by Medicare review of patient dis-
charge charts. Data from one hospital were used to perform
detailed cost/reimbursement analyses. Relevant cases were iden-
tiﬁed by searching with the ICD-9-CM code for hyponatremia
(276.1) drilling down within all DRGs to quantify the incidence
of hyponatremia, associated ﬁnancial impact and costs hypona-
tremia may have. RESULTS: In the 176 hospitals, hyponatremia
was found as a secondary diagnosis or coexisting condition in
16,791 cases. Most common DRGs that included a diagnosis of
hyponatremia were congestive heart failure (CHF, n = 13,778),
syndrome of inappropriate secretion of antidiuretic hormone
(SIADH, n = 1355), and transurethral resection of the prostate
(TURP syndrome, n = 193). Hyponatremia was identiﬁed in
73% (7398/10,073) of complicated CHF cases and in 25%
(6380/25,038) of uncomplicated CHF cases. In a typical hospi-
tal with 190 uncomplicated CHF cases annually, the mean cost
of an uncomplicated CHF case was $6247, whereas the mean
reimbursement was $3667, suggesting a loss of $2580 per case
(annual loss of $490,200). If complicated CHF cases were con-
sidered, the typical hospital’s annual loss was estimated at
$2,883,096. Endocrine disorders including SIADH cost between
$12,305 and $24,745 and are reimbursed at $3,861. New ther-
apies providing predictable correction of serum sodium levels
may mitigate the economic impact of hyponatremia associated
with underlying conditions by reducing the length of stay (LOS),
physician attending time, or frequent laboratory studies. CON-
CLUSIONS: The incidence and economic impact of hypona-
tremia is high among patients with complicated CHF, TURP
syndrome, and SIADH. Improved treatment of hyponatremia
may help relieve this burden.
POT2
FATIGUE IN THE U.S.WORKFORCE: PREVALENCE AND COST
OF LOST PRODUCTIVE WORK TIME
Ricci J, Chee E, Lorandeau A
Caremark, Scottsdale, AZ, USA
OBJECTIVE: To estimate the prevalence of fatigue and accom-
panying lost labor costs (work absence and reduced performance
while at work) among US workers. METHODS: Cross-sectional
study using data from the Caremark American Productivity
Audit, a national random-digit-dial telephone survey of the US
population designed to measure the relation between health and
work productivity. The sample comprised 28,902 employed
adults participating in the audit between August 1, 2001, and
July 30, 2002. A total of 11,719 workers with fatigue were iden-
tiﬁed. A comparison group consisted of a gender- and age-
matched random sample (1 :1) of workers without fatigue.
Outcome measures included fatigue prevalence, lost productive
time (LPT) due to fatigue and LPT for any health-related reason
expressed in hours and converted to dollars. RESULTS: The esti-
mated two-week period prevalence of fatigue in the U.S. work-
force was 37.9%. Overall, 9.2% of workers with fatigue
reported LPT due to fatigue in the previous two weeks. This
group lost 4.1 productive hours per week, on average, and cost
employers an estimated $330 million per year; 83.9% of the LPT
cost was due to reduced performance while at work. Compar-
ing LPT for any health-related reason between workers with and
without fatigue, workers with fatigue cost US employers an esti-
mated $136.4 billion per year in health-related LPT, an annual
excess of $101.0 billion. Excess health-related LPT is primarily
explained by the mean threefold increase in the percent of
workers reporting LPT due to other health conditions when
fatigue is present. CONCLUSIONS: Fatigue is prevalent in the
US workforce and can impair work ability. When present as a
secondary symptom to other health conditions, fatigue is asso-
ciated with signiﬁcantly more LPT due to those conditions.
POT3
COST OF HOSPITALIZATIONS FOR ACUTE INJURIES
RESULTING FROM MOTORCYCLE ACCIDENTS PRE-AND
POST-REPEAL OF THE UNIVERSAL HELMET LAW IN FLORIDA
O’Brien JA1, Pitoniak-Morse C1, Jacobs LM2
1Caro Research Institute, Concord, MA, USA, 2University of
Connecticut, School of Medicine, Farmington, CT, USA
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OBJECTIVES: In July 2000, Florida replaced a Federal law man-
dating all motorcycle riders to wear helmets with a state law
requiring helmets only for those <21 years, or with under $10,000
health insurance. Hospitalizations for motorcycle accident-
related injuries prior to and after the law changed were examined
to understand potential consequences. METHODS: Florida 
hospital databases for 13 quarters prior to January 4, 1997–
June 30, 2000) and after the change July 1, 2000–Septemebr 30,
2003), and published Florida motorcycle crash statistics were
examined. Hospitalized cases with crash-related injuries were
identiﬁed by via Emergency Department, ICD-9 diagnosis and E
codes (E810.2-E825.2, E810.3-E825.3). Injury type, demo-
graphics, costs, length of stay (LOS) and disposition were ana-
lyzed. Charges (accommodations and ancillary services) adjusted
by a 0.46 cost-to-charge ratio and appropriate inﬂation indices
are reported as costs (2005 US$). RESULTS: In the pre-repeal
period, 3914 inpatient motorcycle-related injury cases were iden-
tiﬁed (males: 86%; mean age: 35.6, mean LOS: 6 days); 6424
cases in post-repeal period (males: 87%, mean age: 36.4, mean
LOS: 6 days); due to a rise in reported motorcycle crashes (33%),
all related-injuries (44%) and deaths (66%) during 1997–2003;
however, broader E-code use may also be a factor. Among 
hospitalized cases, there were signiﬁcantly (p < 0.01) more head,
neck and cervical spinal cord injuries (45% vs 35%), and deaths
(2.9% vs. 2.2%) post-repeal. Although average LOS did 
not increase, average cost per day ($4093 vs. $3359), and 
per stay ($20,502 vs. $17,243) increased signiﬁcantly (p < 0.01)
post-repeal. Cumulative cost of inpatient care for motorcycle-
related injuries rose from $68 million to $132 million during this
period. CONCLUSIONS:Since universal helmet requirements
were relaxed, there has been a substantial increase in motorcycle
accident-related injuries overall, head injury hospitalizations, and
injury-related deaths. Beyond clinical and societal consequences,
these increases reﬂect an increased economic burden as well.
PAIN—Clinical Outcomes Studies
PPN1
OPIOID ASSOCIATED ERECTILE DISFUNCTION IN CHRONIC
PAIN PATIENTS
Marsh B1, Sampson JM
1North Florida /South Georgia VA Medical Center, Gainesville, FL,
USA
OBJECTIVES: To study the prevalence of erectile disorder in
males with chronic pain on opioids. Chronic pain can lead to
reduced quality of life and strain on relationships. Opioids them-
selves can lead to signiﬁcant side effects, including a reduction
in serum testosterone and interference in the hypothalamic—
pituitary-axis. METHODS: Male patients in an opioid clinic
with chronic pain on opioids were screened for erectile disorder.
RESULTS: Ninety ﬁve patients were screened and 27 patients
29%) were positive for the disorder. Only ten (37%) had
received treatment. CONCLUSIONS: Erectile disorder is an
under diagnosed and treated disorder in chronic pain patients on
opioids. Male patients with chronic pain should be routinely
screened for erectile disorders.
PAIN—Cost Studies
PPN2
IMPACT OF BACK PAIN ON ABSENTEEISM, PRODUCTIVITY
LOSS,AND DIRECT HEALTH CARE COSTS USING THE
MEDICAL EXPENDITURE PANEL SURVEY (MEPS)
Parthan A, Shepherd MD, Lawson KA, Barner JC, Brown C,
Bohman T
University of Texas at Austin, Austin,TX, USA
OBJECTIVE: The objective of this study was to assess the impact
of back pain on absenteeism, productivity loss, and direct health
care costs using the Medical Expenditure Panel Survey (MEPS).
METHODS: Individuals between the ages of 18 and 65 years
who participated in the MEPS during 2000 were included in the
study. Back pain patients were identiﬁed using ICD-9 codes. The
predictors of absenteeism in individuals who experienced back
pain were identiﬁed using Zero-inﬂated negative binomial regres-
sion (ZINB). Absenteeism days due to back pain were estimated
based on the ZINB regression model. Productivity loss was esti-
mated using the human capital approach. RESULTS: In 2000,
the one-year period prevalence of back pain in individuals
between 18 and 65 years of age was 11.1%. About 16.3% of
the individuals who were employed and who reported back pain
experienced back pain due to work-related injuries. Ethnicity
and union contract were identiﬁed as signiﬁcant predictors of
likelihood of absenteeism in individuals who experienced back
pain. The signiﬁcant predictors of absenteeism rate were per-
ceived overall health status due to back pain, and ethnicity. The
mean number of absenteeism days due to back pain was esti-
mated to be six days and a total of nine million absenteeism days
were due to back pain. The total productivity loss due to back
pain-related absenteeism was estimated to be $3.6 billion and
the total direct health care costs was estimated to be $14 billion.
The average productivity loss due to back pain was estimated to
be $305 per person and the annual per-capita direct health care
cost due to back pain was $730. CONCLUSIONS: Back pain is
one of the most common and challenging problems in primary
care. The economic burden due to back pain is of concern to
employers, insurance agencies, policy decision makers and treat-
ment decision makers.
PAIN—Health Care Use & Policy
PPN3
THE PRICING AND DISTRIBUTION OF REPACKAGED DRUGS:
COST EFFECTS IN THE CALIFORNIA WORKERS’
COMPENSATION SYSTEM
Gitlin M1,Wilson L2
1University of California, San Francisco and Amgen, Inc, San Francisco,
CA, USA, 2University of California, San Francisco, San Francisco, CA,
USA
OBJECTIVE: The California Workers’ Compensation (WC)
drug pricing system effective in 2004 tied payments to the Medi-
Cal system, but 60% of National Drug Codes (NDC) in the WC
System lacked an equivalent Medi-Cal NDC; and many were
repackaged pharmaceuticals. A model of pharmaceutical distri-
bution and claims processing of repackaged pharmaceuticals was
deﬁned. We assessed the cost and utilization of repackaged phar-
maceuticals to determine potential lost savings to the California
WC system. METHODS: We used 2002 data from the Califor-
nia Workers’ Compensation Institute and Medi-Cal pharmacy
expenditures. We described the extent of lost savings due to
repackaged pharmaceuticals, compared the characteristics of
repackaged pharmaceuticals in the WC using ANOVA, and iden-
tiﬁed predictors of repackaged pharmaceuticals using GLM
regression. We also suggest alternative pricing systems for Medi-
Cal non-equivalent repackaged NDCs. RESULTS: Repackaged
pharmaceuticals represented 55% of the Medi-Cal non-
equivalent NDCs used, but only 21% of total WC costs
($8,494,297) were attributed to repackaged pharmaceuticals.
Approximately 88% of repackaged pharmaceutical costs were
for generic medications. Companies most commonly associated
with repackaged pharmaceutical costs were Southwood Phar-
maceuticals (33.1%) and Pharma Pac (31.7%). Overall, com-
